Monograph
C10AD02 - Nicotinic Acid |
Not porphyrinogenic |
NP |
Rationale
No data pointing to CYP-interactions. One reference stating probable non-porphyrinogenicity.
Chemical description
Used in hyperlipidemia. No data pointing to CYP-interaction. South African list: use with care
Similar drugs
Tradenames and packages
From some sources, we get a list of packages (United Kingdom, Ireland, Estonia).
Other sources contain more or less "clean" versions of the trade name (Denmark, Finland, Iceland, Lithuania, Norway).
What you see here is the raw data we get from each country, so there will appear to be duplicates. The bold names
are the searchable terms. The gray names that follow are all mapped to the bolded term.
Note: The cleaning is done automatically by a proprietary algorithm, and it may produce errors.
We strive to improve it continuously.
United Kingdom
Niacin · Solgar Niacin 500mg capsules · Niaspan · Niaspan 1g modified-release tablets · Niaspan 375mg modified-release tablets · Niaspan 500mg modified-release tablets · Niaspan 750mg modified-release tablets · Nicotinic acid · Nicotinic acid 500mg modified-release tablets · Nicotinic acid 500mg oral powder sachets
© NAPOS 2024